Vystar Announces 2-Week-Long Memorabilia Sweepstakes on X Platform
Globenewswire· 2026-02-18 14:30
Worcester, Massachusetts, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Vystar Corporation (OTCQB: VYST), a diversified innovation company with operations spanning eco-friendly products and collectibles monetization, today announced to increase awareness and drive exposure to the GoPaid platform and its collectibles ecosystem with an emphasis on the tokenization of collectibles will conduct a free sweepstakes for the next 14 days. Following the release, we will coordinate a focused social media push on X. This campaign ...
Broad Arrow Named as the Official Auction Partner of The Quail, A Motorsports Gathering
Globenewswire· 2026-02-18 14:30
Core Insights - Broad Arrow has announced a multi-year partnership with The Quail, A Motorsports Gathering, to become the official auction partner for the event, marking a significant evolution in its status as a premier collector car auction company [1][4] Auction Details - The two-day auction is scheduled for August 13 and 14, 2026, at The Quail Golf Club, featuring approximately 175 highly sought-after collector cars, including pre- and post-war classics, motorsport icons, and rare supercars [2][5] - The partnership aims to enhance The Quail's auction platform and provide visitors with expanded opportunities to engage with luxury automotive experiences [2] Event Highlights - The Quail, A Motorsports Gathering will showcase over a dozen vehicle debuts from top OEMs and designers, alongside a curated display of unique vehicles and world-class cuisine [3] - This year's event will focus on four celebrated classes: The 100th Anniversary of Route 66, The Lamborghini Diablo, The Legacy of Japanese GTs, and The Ferrari F40 [3] Company Growth - Broad Arrow has rapidly grown since its founding in 2021, achieving a total transaction value of over $624 million in 2025, representing a 97% increase from 2024 [5] - The company sold $257 million across eight live auctions in 2025, with an overall sell-through rate of 88% for 949 lots sold, including 642 cars [5][8] Integration with Motorlux - Broad Arrow will maintain a strong presence at Motorlux, the iconic opening night of Monterey Car Week, providing auction previews and assisting clients with registration [9]
Uniti Wholesale Accelerates 2026 Expansion; FastWaves™ Delivers 100G/400G in Days, Not Months
Globenewswire· 2026-02-18 14:30
LITTLE ROCK, Ark., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Uniti Wholesale today announced accelerated progress on its 2026 expansion plan, including new data center on-ramps, key route upgrades, and the launch of FastWaves™—a pre-deployed optical capacity program designed to cut delivery intervals for 100G and 400G wavelength services to less than three weeks on select routes. These initiatives expand the company’s reach to critical U.S. data centers while pairing faster turn-ups with market-aligned pricing and ...
Trident Closes $18.6 Million Offering
Globenewswire· 2026-02-18 14:24
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Vancouver, BC, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company”) is pleased to announce that it has closed its previously announced private placements (please refer to the Company’s January 27th, 2026, and February 2nd, 2026 news releases). A total of 4,948,000 common shares of the Company that qualify as “flow-through shares” within the meaning of subsection ...
RESULTS OF MEETING OF THE ETP SECURITYHOLDERS
Globenewswire· 2026-02-18 14:19
18 February 2026 LSE Code: 3HCS WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY(a public company incorporated with limited liability in Ireland)WISDOMTREE COPPER 3X DAILY SHORT SECURITIES ISIN: IE00B8KD3F05 RESULTS OF MEETING OF THE ETP SECURITYHOLDERS WisdomTree Multi Asset Issuer Public Limited Company (the “Issuer”) wishes to announce that the Extraordinary Resolution regarding the reduction in the principal amount of the WisdomTree Copper 3x Daily Short Securities (the “Affected Securities”) from U ...
PRF Technologies’ DeepSolar Announces its First Commercial Due Diligence Engagement with EDF Power Solutions Israel, a Global Leader in Renewable Energy
Globenewswire· 2026-02-18 14:15
Agreement Initiates Data-Driven Technical Due Diligence of an Operational, Utility-Scale Solar Asset in IsraelTEL AVIV, Israel, Feb. 18, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”) (formerly “PainReform”) today announced that its DeepSolar business unit has entered into a solar analytics services agreement with a subsidiary of EDF Group (Electricite’ De France, France’s Electric Company, one of the largest international energy companies), a global leader in renewab ...
Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY
Globenewswire· 2026-02-18 14:11
Core Insights - Prenetics Global Limited achieved record financial results in 2025, driven by the strong performance of its IM8 brand, marking a transformational year for the company [2][3][28] Financial Performance - Full-year revenue surged approximately 480% year-over-year to $92.4 million, with fourth quarter revenue reaching $36.6 million, a 55% increase quarter-over-quarter [3][41] - IM8 contributed $60.1 million in revenue for FY2025 and achieved an annualized recurring revenue (ARR) of approximately $120 million within just 12 months of launch [3][28] - Adjusted EBITDA loss improved by 27.2% year-over-year to $(13.0) million for FY2025, reflecting the capital efficiency of the IM8 business model [43][40] Strategic Actions - The company divested ACT Genomics for up to $72 million, sold the Europa distribution business for up to $13 million, and sold its stake in Insighta to Tencent for $70 million, enhancing its balance sheet to approximately $171 million in total adjusted liquidity [2][27][31] - The strategic transformation focused on streamlining operations and positioning IM8 as the core growth engine, resulting in a simplified operating structure [2][24][26] IM8 Brand Growth - IM8 was the primary growth driver, achieving a monthly revenue of $10 million in December 2025, with a 51% growth from Q3 to Q4 [4][3] - The brand's global reach expanded significantly, with over 60% of revenue generated outside the United States, indicating strong international demand [13][12] Customer Metrics - The total customer orders exceeded 230,000 in Q4 2025, with a 35% increase from Q3 [7] - The average order value increased to $133 in Q4 2025, reflecting a 31% growth from the previous quarter [7][18] Future Outlook - The company expects to triple IM8 revenue in 2026, targeting $180 million to $200 million, with a path towards $250 million to $300 million in ARR by the end of 2026 [30][32] - The transition to quarterly subscription plans is anticipated to enhance cash flow and customer lifetime value, with new blended average order values reaching approximately $233 in early 2026 [15][29]
Big Village, A Bright Mountain Company, Joins Indie Agency News as Preferred Data and Insights Partner
Globenewswire· 2026-02-18 14:10
Partnership gives independent agencies access to Audience Intelligence tools designed to sharpen targeting and close the data gap with holding company competitors Boca Raton, FL, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Bright Mountain Media, Inc. (OTCQB: BMTM) ("Bright Mountain" or the "Company"), a marketing services platform, today announced that Big Village has become a Preferred Data and Insights Partner within Indie Agency News' newly launched Preferred Partner Program. Independent agencies are under increas ...
U.S. Cyber Command Issues Parsons' Subsidiary Intent to Award for Joint Cyber Hunt Kit (JCHK) Production
Globenewswire· 2026-02-18 14:05
Core Insights - Sealing Technologies (SealingTech), a subsidiary of Parsons Corporation, has received an Intent to Award notification from the United States Cyber Command for a sole-source contract to produce the Joint Cyber Hunt Kit solution, with a potential value of up to $500 million over three years [1][2]. Group 1: Company Developments - The contract marks a significant step in SealingTech's collaboration with the Department of War's Defense Innovation Unit and USCYBERCOM, focusing on advanced defensive cyber technologies [2]. - Parsons acquired SealingTech in 2023 to enhance its cyber operations capabilities for the Defense and Intelligence sectors, aiming to solidify its leadership in national security [2][3]. - SealingTech has a decade-long history of supporting the U.S. Department of War, having deployed over 500 Cyber Fly-Away Kits for critical national security missions [3]. Group 2: Strategic Vision - Parsons emphasizes its commitment to providing mission-ready solutions that ensure the U.S. military's operational superiority [3]. - The collaboration with DIU and USCYBERCOM aims to advance next-generation defensive cyber capabilities, enhancing the tactical advantage of warfighters [4]. - Parsons integrates various cyber capabilities, including offensive and defensive operations, to deliver transformative solutions that support multi-domain operations [4].
Akari Therapeutics to Present at the 2026 Biocom Global Partnering & Investor Conference
Globenewswire· 2026-02-18 14:05
Core Insights - Akari Therapeutics is set to present at the 2026 Biocom Global Partnering & Investor Conference, highlighting its focus on oncology biotechnology and antibody drug conjugates (ADCs) with novel immuno-oncology payloads [1][2]. Company Overview - Akari Therapeutics specializes in developing next-generation ADCs, particularly focusing on a unique payload, PH1, which targets RNA splicing [3]. - The lead candidate, AKTX-101, targets the Trop2 receptor on cancer cells and utilizes a proprietary linker to deliver the PH1 payload directly into tumors, minimizing off-target effects [3]. - PH1 is a spliceosome modulator designed to disrupt RNA splicing in cancer cells, showing potential to induce cancer cell death while activating both innate and adaptive immune responses [3]. - Preclinical studies indicate that AKTX-101 has significant activity and prolonged survival compared to traditional ADCs, with potential synergy when combined with checkpoint inhibitors [3]. - The company has initiated IND enabling studies for AKTX-101, aiming to start its First-In-Human trial by late 2026 or early 2027 [3]. - Akari is also developing AKTX-102, targeting CEACAM5, a tumor antigen expressed in various solid tumors, leveraging the PH1 payload for enhanced tumor cell killing and immune activation [3].